Chief Scientific Officer:This must be Peter Richardson's replacement.

"This February, Anders Boss, CSO, Mannkind Corporation will be looking more in-depth at the blood sugar drugs that are coming to the market in the presentation "Breakthroughs in Insulin Pharmacodynamics: The State of the Art and the Shape of the Future" at the first annual Innovation and Commercialization of Therapeutics for Metabolic Disorders. For more information on this presentation and the rest of the program, download the agenda. If you'd like to join us, register today and mention code XP1803BLOG to save 15% off the standard rate. "

http://futurebiopharma.blogspot.com/2012/10/merck-developing-new-one-dose-weekly.html